| Autor: |
MIKE GRADY, HILARY CAMERON, ELIZABETH H. HOLT |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
Diabetes. 71 |
| ISSN: |
0012-1797 |
| Popis: |
Background: The OneTouch Verio Reflect® (OTVR) meter provides advanced Color Range and Blood Sugar Mentor™ features that are complemented by the OneTouch Reveal® (OTR) app. We sought to provide evidence that these products support improved glycemic control. Methods: Anonymous glucose and app analytics were extracted from our server for 1627 people with type 1 diabetes (T1D) and 5353 people with type 2 diabetes (T2D) . Data from their first 14 days was compared to 14 days prior to a 180 day timepoint using paired within-subject differences. Results: Percentage glucose readings in-range (70-180mg/dl) improved by 6.0% (from 58.9 to 64.8%) in T1Ds and by 10.7% (from 73.2 to 83.9%) in T2Ds. Hyperglycemic readings (>180mg/dl) reduced by -6.5% (from 36.4 to 29.9%) in T1Ds and by -10.8% (from 25.7 to 14.9%) in T2Ds. Mean glucose reduced on average by -11.4mg/dl (from 173.9 to 162.5mg/dl) in T1Ds and by -17.3mg/dl (from 156.8 to 139.5) in T2Ds. 2 to 3 sessions per week or 11 to 20 minutes per week on the OTR app improved readings in-range in T1Ds by 5% or 6%, respectively (see graphs below) . Similar trends were observed in people with T2D. Conclusion: Real world data from nearly 7000 people with diabetes demonstrates significantly improved readings in-range and lower mean glucose in those using the OneTouch Verio Reflect® meter and OneTouch Reveal® app. Disclosure M. Grady: Employee; LifeScan. H. Cameron: None. E. H. Holt: Employee; Intarcia Therapeutics, Inc., LifeScan. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
